Overall survival (1‐year · people with pancreatic and periampullary adenocarcinoma
It is very uncertain whether extended changes overall survival (1‐year compared with standard lymph node resection (very low certainty).
1 finding from 1 review
Overall survival (3‐year · people with pancreatic and periampullary adenocarcinoma
It is very uncertain whether extended changes overall survival (3‐year compared with standard lymph node resection (very low certainty).
1 finding from 1 review
Postoperative mortality (duration of · people with pancreatic and periampullary adenocarcinoma
Extended showed no clear difference in postoperative mortality (duration of compared with standard lymph node resection (low certainty).
1 finding from 1 review
Operating time · people with pancreatic and periampullary adenocarcinoma
1 finding from 1 review
Blood loss · people with pancreatic and periampullary adenocarcinoma
1 finding from 1 review
Lymph nodes retrieved · people with pancreatic and periampullary adenocarcinoma
1 finding from 1 review
Positive resection margins · people with pancreatic and periampullary adenocarcinoma
It is very uncertain whether extended changes positive resection margins (R1 + R2) compared with standard lymph node resection (very low certainty).
1 finding from 1 review
CMV disease · solid organ transplant recipients
Extended probably leads to lower CMV disease compared with short‐duration valganciclovir (moderate certainty).
1 finding from 1 review
All‐cause death · solid organ transplant recipients
Extended showed no clear difference in all‐cause death compared with short‐duration valganciclovir (low certainty).
1 finding from 1 review
CMV syndrome · solid organ transplant recipients
Extended probably leads to lower CMV syndrome compared with short‐duration valganciclovir (moderate certainty).
1 finding from 1 review
CMV infection · solid organ transplant recipients
Extended may leads to lower CMV infection compared with short‐duration valganciclovir (low certainty).
1 finding from 1 review
Acute rejection · solid organ transplant recipients
Extended probably leads to lower acute rejection compared with short‐duration valganciclovir (moderate certainty).
1 finding from 1 review
Opportunistic infections · solid organ transplant recipients
Extended showed no clear difference in opportunistic infections compared with short‐duration valganciclovir (low certainty).
1 finding from 1 review
Total treatment‐related adverse effects · solid organ transplant recipients
Extended showed no clear difference in total treatment‐related adverse effects compared with short‐duration valganciclovir (moderate certainty).
1 finding from 1 review
Surgical site infections: liver transplant recipients Time frame: 30 days · solid organ transplant recipients
It is very uncertain whether extended changes surgical site infections: liver transplant recipients Time frame: 30… compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Death (any case) Time frame: 2 to 4 weeks · solid organ transplant recipients
It is very uncertain whether extended changes death (any cause) Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Graft loss including death · solid organ transplant recipients
It is very uncertain whether extended changes graft loss (including death with functioning graft) Time frame: 30… compared with short duration antibiotics (very low certainty).
1 finding from 1 review
UTI · solid organ transplant recipients
It is very uncertain whether extended changes other infection: UTI Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Other infection: septicaemia Time frame: 2 to 6 weeks · solid organ transplant recipients
It is very uncertain whether extended changes other infection: septicaemia Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Other infection: pneumonia Time frame: 30 days · solid organ transplant recipients
It is very uncertain whether extended changes other infection: pneumonia Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review